{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T00:19:20Z","timestamp":1724372360044},"reference-count":138,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,21]]},"DOI":"10.7759\/cureus.67359","type":"journal-article","created":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:34:57Z","timestamp":1724286897000},"source":"Crossref","is-referenced-by-count":0,"title":["Ensuring Transfusion Safety: Screening Blood Donors for Human Parvovirus B19"],"prefix":"10.7759","author":[{"given":"Swati","family":"Kumari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reuben Kuruvilla","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishanamoorthy","family":"R","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramya","family":"Barani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Padma","family":"Srikanth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.21037\/aob-21-60","article-title":"Transfusion-transmitted infections","volume":"7","author":"Bloch EM","year":"2022","unstructured":"Bloch EM. Transfusion-transmitted infections. Ann Blood. 2022, 7:20. 10.21037\/aob-21-60","journal-title":"Ann Blood"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0265951","article-title":"The clinical demand and supply of blood in India: a national level estimation study","volume":"17","author":"Mammen JJ","year":"2022","unstructured":"Mammen JJ, Asirvatham ES, Lakshmanan J, et al.. The clinical demand and supply of blood in India: a national level estimation study. PLoS One. 2022, 17:e0265951. 10.1371\/journal.pone.0265951","journal-title":"PLoS One"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-11-833996","article-title":"Prevention of transfusion-transmitted infections","volume":"133","author":"Busch MP","year":"2019","unstructured":"Busch MP, Bloch EM, Kleinman S. Prevention of transfusion-transmitted infections. Blood. 2019, 133:1854-64. 10.1182\/blood-2018-11-833996","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2006.09.016","article-title":"Emerging infectious diseases that threaten the blood supply","volume":"44","author":"Alter HJ","year":"2007","unstructured":"Alter HJ, Stramer SL, Dodd RY. Emerging infectious diseases that threaten the blood supply. Semin Hematol. 2007, 44:32-41. 10.1053\/j.seminhematol.2006.09.016","journal-title":"Semin Hematol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/412105","article-title":"Screening donated blood for transfusion transmitted infections by serology along with NAT and response rate to notification of reactive results: an Indian experience","volume":"2014","author":"Chaurasia R","year":"2014","unstructured":"Chaurasia R, Zaman S, Das B, Chatterjee K. Screening donated blood for transfusion transmitted infections by serology along with NAT and response rate to notification of reactive results: an Indian experience. J Blood Transfus. 2014, 2014:412105. 10.1155\/2014\/412105","journal-title":"J Blood Transfus"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-03-1053","article-title":"Persistent B19 infection in immunocompetent individuals: implications for transfusion safety","volume":"106","author":"Lefrere JJ","year":"2005","unstructured":"Lefrere JJ, Servant-Delmas A, Candotti D, et al.. Persistent B19 infection in immunocompetent individuals: implications for transfusion safety. Blood. 2005, 106:2890-5. 10.1182\/blood-2005-03-1053","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)04719-4","article-title":"Hepatitis C virus transmission by a blood donation negative in nucleic acid amplification tests for viral RNA","volume":"355","author":"Sch\u00fcttler CG","year":"2000","unstructured":"Sch\u00fcttler CG, Caspari G, Jursch CA, Willems WR, Gerlich WH, Schaefer S. Hepatitis C virus transmission by a blood donation negative in nucleic acid amplification tests for viral RNA. Lancet. 2000, 355:41-2. 10.1016\/S0140-6736(99)04719-4","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-5-25","article-title":"Transfusion-transmitted infections","volume":"5","author":"Bihl F","year":"2007","unstructured":"Bihl F, Castelli D, Marincola F, Dodd RY, Brander C. Transfusion-transmitted infections. J Transl Med. 2007, 5:25. 10.1186\/1479-5876-5-25","journal-title":"J Transl Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/s0934-8840(11)80616-x","article-title":"Heat stability of parvovirus B19: kinetics of inactivation","volume":"277","author":"Schwarz TF","year":"1992","unstructured":"Schwarz TF, Serke S, Von Brunn A, Hottentr\u00e4ger B, Huhn D, Deinhardt F, Roggendorf M. Heat stability of parvovirus B19: kinetics of inactivation. Zentralbl Bakteriol. 1992, 277:219-23. 10.1016\/s0934-8840(11)80616-x","journal-title":"Zentralbl Bakteriol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-015-0396-z","article-title":"Prevalence of human parvovirus B19 in Chinese plasma pools for manufacturing plasma derivatives","volume":"12","author":"Jia J","year":"2015","unstructured":"Jia J, Ma Y, Zhao X, et al.. Prevalence of human parvovirus B19 in Chinese plasma pools for manufacturing plasma derivatives. Virol J. 2015, 12:162. 10.1186\/s12985-015-0396-z","journal-title":"Virol J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12060","article-title":"Parvovirus transmission by blood products - a cause for concern?","volume":"159","author":"Norja P","year":"2012","unstructured":"Norja P, Lassila R, Makris M. Parvovirus transmission by blood products - a cause for concern?. Br J Haematol. 2012, 159:385-93. 10.1111\/bjh.12060","journal-title":"Br J Haematol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00705-013-1914-1","article-title":"The family Parvoviridae","volume":"159","author":"Cotmore SF","year":"2014","unstructured":"Cotmore SF, Agbandje-McKenna M, Chiorini JA, et al.. The family Parvoviridae. Arch Virol. 2014, 159:1239-47. 10.1007\/s00705-013-1914-1","journal-title":"Arch Virol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(75)91074-0","article-title":"Parvovirus-like particles in human sera","volume":"1","author":"Cossart YE","year":"1975","unstructured":"Cossart YE, Field AM, Cant B, Widdows D. Parvovirus-like particles in human sera. Lancet. 1975, 1:72-3. 10.1016\/s0140-6736(75)91074-0","journal-title":"Lancet"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.58.3.921-936.1986","article-title":"Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis","volume":"58","author":"Shade RO","year":"1986","unstructured":"Shade RO, Blundell MC, Cotmore SF, Tattersall P, Astell CR. Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis. J Virol. 1986, 58:921-36. 10.1128\/JVI.58.3.921-936.1986","journal-title":"J Virol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.61.8.2627-2630.1987","article-title":"Characterization of capsid and noncapsid proteins of B19 parvovirus propagated in human erythroid bone marrow cell cultures","volume":"61","author":"Ozawa K","year":"1987","unstructured":"Ozawa K, Young N. Characterization of capsid and noncapsid proteins of B19 parvovirus propagated in human erythroid bone marrow cell cultures. J Virol. 1987, 61:2627-30. 10.1128\/JVI.61.8.2627-2630.1987","journal-title":"J Virol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/s1534-5807(01)00031-4","article-title":"A viral phospholipase A2 is required for parvovirus infectivity","volume":"1","author":"Z\u00e1dori Z","year":"2001","unstructured":"Z\u00e1dori Z, Szelei J, Lacoste MC, et al.. A viral phospholipase A2 is required for parvovirus infectivity. Dev Cell. 2001, 1:291-302. 10.1016\/s1534-5807(01)00031-4","journal-title":"Dev Cell"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1006\/viro.2001.1285","article-title":"NS1 protein of parvovirus B19 interacts directly with DNA sequences of the p6 promoter and with the cellular transcription factors Sp1\/Sp3","volume":"293","author":"Raab U","year":"2002","unstructured":"Raab U, Beckenlehner K, Lowin T, Niller HH, Doyle S, Modrow S. NS1 protein of parvovirus B19 interacts directly with DNA sequences of the p6 promoter and with the cellular transcription factors Sp1\/Sp3. Virology. 2002, 293:86-93. 10.1006\/viro.2001.1285","journal-title":"Virology"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.76.18.9124-9134.2002","article-title":"Genetic diversity within human erythroviruses: identification of three genotypes","volume":"76","author":"Servant A","year":"2002","unstructured":"Servant A, Laperche S, Lallemand F, Marinho V, De Saint Maur G, Meritet JF, Garbarg-Chenon A. Genetic diversity within human erythroviruses: identification of three genotypes. J Virol. 2002, 76:9124-34. 10.1128\/jvi.76.18.9124-9134.2002","journal-title":"J Virol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01970-13","article-title":"Keeping pace with parvovirus B19 genetic variability: a multiplex genotype-specific quantitative PCR assay","volume":"51","author":"Bonvicini F","year":"2013","unstructured":"Bonvicini F, Manaresi E, Bua G, Venturoli S, Gallinella G. Keeping pace with parvovirus B19 genetic variability: a multiplex genotype-specific quantitative PCR assay. J Clin Microbiol. 2013, 51:3753-9. 10.1128\/JCM.01970-13","journal-title":"J Clin Microbiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.15.3.485-505.2002","article-title":"Human parvovirus B19","volume":"15","author":"Heegaard ED","year":"2002","unstructured":"Heegaard ED, Brown KE. Human parvovirus B19. Clin Microbiol Rev. 2002, 15:485-505. 10.1128\/CMR.15.3.485-505.2002","journal-title":"Clin Microbiol Rev"},{"key":"ref21","article-title":"[Detection of parvovirus B19 markers in blood samples of donors]","author":"Filatova EV","year":"2010","unstructured":"Filatova EV, Zubkova NV, Novikova NA, Golitsina LN, Kuznetsov KV. [Detection of parvovirus B19 markers in blood samples of donors]. Zh Mikrobiol Epidemiol Immunobiol. 2010, 67-70.","journal-title":"Zh Mikrobiol Epidemiol Immunobiol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2006.01697.x","article-title":"Clinical aspects of parvovirus B19 infection","volume":"260","author":"Broliden K","year":"2006","unstructured":"Broliden K, Tolfvenstam T, Norbeck O. Clinical aspects of parvovirus B19 infection. J Intern Med. 2006, 260:285-304. 10.1111\/j.1365-2796.2006.01697.x","journal-title":"J Intern Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/v16020180","article-title":"Seroepidemiology of human parvovirus B19 infection among the population of Vojvodina, Serbia, over a 16-year period (2008-2023)","volume":"16","author":"Vukovi\u0107 V","year":"2024","unstructured":"Vukovi\u0107 V, Pati\u0107 A, Risti\u0107 M, Kova\u010devi\u0107 G, Hrnjakovi\u0107 Cvjetkovi\u0107 I, Petrovi\u0107 V. Seroepidemiology of human parvovirus B19 infection among the population of Vojvodina, Serbia, over a 16-year period (2008-2023). Viruses. 2024, 16:180. 10.3390\/v16020180","journal-title":"Viruses"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3390\/v13040540","article-title":"Prevalence and phylogenetic analysis of parvovirus (B19V) among blood donors with different nationalities residing in Qatar","volume":"13","author":"Abdelrahman D","year":"2021","unstructured":"Abdelrahman D, Al-Sadeq DW, Smatti MK, et al.. Prevalence and phylogenetic analysis of parvovirus (B19V) among blood donors with different nationalities residing in Qatar. Viruses. 2021, 13:540. 10.3390\/v13040540","journal-title":"Viruses"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.4314\/ahs.v18i3.5","article-title":"Seroprevalence of parvovirus B19 in blood donors: the risks and challenges of blood transfusion in Zambia in the era of HIV\/AIDS at the Kitwe Central Hospital, blood bank","volume":"18","author":"Chirambo-Kalolekesha M","year":"2018","unstructured":"Chirambo-Kalolekesha M, Kaile T, Mwaba F, Daka V, Simakando M, Kowa S. Seroprevalence of parvovirus B19 in blood donors: the risks and challenges of blood transfusion in Zambia in the era of HIV\/AIDS at the Kitwe Central Hospital, blood bank. Afr Health Sci. 2018, 18:496-502. 10.4314\/ahs.v18i3.5","journal-title":"Afr Health Sci"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-198708000-00003","article-title":"Role of parvovirus B19 in human disease","volume":"6","author":"Anderson LJ","year":"1987","unstructured":"Anderson LJ. Role of parvovirus B19 in human disease. Pediatr Infect Dis J. 1987, 6:711-8. 10.1097\/00006454-198708000-00003","journal-title":"Pediatr Infect Dis J"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.648","article-title":"The expanding range of parvoviruses which infect humans","volume":"20","author":"Brown KE","year":"2010","unstructured":"Brown KE. The expanding range of parvoviruses which infect humans. Rev Med Virol. 2010, 20:231-44. 10.1002\/rmv.648","journal-title":"Rev Med Virol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/0268-960X(87)90020-8","article-title":"B19 virus\u2014a pathogenic human parvovirus","volume":"1","author":"Pattison JR","year":"1987","unstructured":"Pattison JR. B19 virus\u2014a pathogenic human parvovirus. Blood Rev. 1987, 1:58-64. 10.1016\/0268-960X(87)90020-8","journal-title":"Blood Rev"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1002\/pd.3930","article-title":"Parvovirus B19 in pregnancy: possible consequences of vertical transmission","volume":"32","author":"Puccetti C","year":"2012","unstructured":"Puccetti C, Contoli M, Bonvicini F, et al.. Parvovirus B19 in pregnancy: possible consequences of vertical transmission. Prenat Diagn. 2012, 32:897-902. 10.1002\/pd.3930","journal-title":"Prenat Diagn"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S356174","article-title":"Environmental monitoring of parvovirus B19 in the kidney transplantation ward of a Chinese teaching hospital","volume":"15","author":"Wang F","year":"2022","unstructured":"Wang F, Zhan Q, Yu SP, Feng HT, Hu P, Zhong ZF, Qu TT. Environmental monitoring of parvovirus B19 in the kidney transplantation ward of a Chinese teaching hospital. Infect Drug Resist. 2022, 15:1903-10. 10.2147\/IDR.S356174","journal-title":"Infect Drug Resist"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/152.2.257","article-title":"Experimental parvoviral infection in humans","volume":"152","author":"Anderson MJ","year":"1985","unstructured":"Anderson MJ, Higgins PG, Davis LR, et al.. Experimental parvoviral infection in humans. J Infect Dis. 1985, 152:257-65. 10.1093\/infdis\/152.2.257","journal-title":"J Infect Dis"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.24.4.522-526.1986","article-title":"Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay","volume":"24","author":"Anderson LJ","year":"1986","unstructured":"Anderson LJ, Tsou C, Parker RA, Chorba TL, Wulff H, Tattersall P, Mortimer PP. Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay. J Clin Microbiol. 1986, 24:522-6. 10.1128\/jcm.24.4.522-526.1986","journal-title":"J Clin Microbiol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.67.6.3004-3009.1993","article-title":"Neutralizing linear epitopes of B19 parvovirus cluster in the VP1 unique and VP1-VP2 junction regions","volume":"67","author":"Saikawa T","year":"1993","unstructured":"Saikawa T, Anderson S, Momoeda M, Kajigaya S, Young NS. Neutralizing linear epitopes of B19 parvovirus cluster in the VP1 unique and VP1-VP2 junction regions. J Virol. 1993, 67:3004-9. 10.1128\/JVI.67.6.3004-3009.1993","journal-title":"J Virol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1989.00390050111022","article-title":"Clinical manifestations of human parvovirus B19 in adults","volume":"149","author":"Woolf AD","year":"1989","unstructured":"Woolf AD, Campion GV, Chishick A, et al.. Clinical manifestations of human parvovirus B19 in adults. Arch Intern Med. 1989, 149:1153-6. 10.1001\/archinte.1989.00390050111022","journal-title":"Arch Intern Med"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198507113130203","article-title":"An erythema infectiosum-like illness caused by human parvovirus infection","volume":"313","author":"Plummer FA","year":"1985","unstructured":"Plummer FA, Hammond GW, Forward K, et al.. An erythema infectiosum-like illness caused by human parvovirus infection. N Engl J Med. 1985, 313:74-9. 10.1056\/NEJM198507113130203","journal-title":"N Engl J Med"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.2450\/2014.0174.14","article-title":"Human parvovirus B19 and blood product safety: a tale of twenty years of improvements","volume":"13","author":"Marano G","year":"2015","unstructured":"Marano G, Vaglio S, Pupella S, et al.. Human parvovirus B19 and blood product safety: a tale of twenty years of improvements. Blood Transfus. 2015, 13:184-96. 10.2450\/2014.0174.14","journal-title":"Blood Transfus"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2010.02749.x","article-title":"Parvovirus B19 infection in human pregnancy","volume":"118","author":"Lamont RF","year":"2011","unstructured":"Lamont RF, Sobel JD, Vaisbuch E, et al.. Parvovirus B19 infection in human pregnancy. BJOG. 2011, 118:175-86. 10.1111\/j.1471-0528.2010.02749.x","journal-title":"BJOG"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01241.x","article-title":"Haematological parameters of parvovirus B19 infection in 13 fetuses with hydrops foetalis","volume":"104","author":"Forestier F","year":"1999","unstructured":"Forestier F, Tissot JD, Vial Y, Daffos F, Hohlfeld P. Haematological parameters of parvovirus B19 infection in 13 fetuses with hydrops foetalis. Br J Haematol. 1999, 104:925-7. 10.1046\/j.1365-2141.1999.01241.x","journal-title":"Br J Haematol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2015-203455","article-title":"The role of parvovirus B19 in the pathogenesis of autoimmunity and autoimmune disease","volume":"69","author":"Kerr JR","year":"2016","unstructured":"Kerr JR. The role of parvovirus B19 in the pathogenesis of autoimmunity and autoimmune disease. J Clin Pathol. 2016, 69:279-91. 10.1136\/jclinpath-2015-203455","journal-title":"J Clin Pathol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511575778","article-title":"Clinical and Diagnostic Virology","author":"Wreghitt T","year":"2009","unstructured":"Wreghitt T, Kudesia G. Clinical and Diagnostic Virology. Cambridge university press, Cambridge, ENG; 2009. 10.1017\/CBO9780511575778"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(85)91146-8","article-title":"Human parvovirus-associated arthritis: a clinical and laboratory description","volume":"23","author":"Reid DM","year":"1985","unstructured":"Reid DM, Reid TM, Brown T, Rennie JA, Eastmond CJ. Human parvovirus-associated arthritis: a clinical and laboratory description. Lancet. 1985, 23:422-5. 10.1016\/s0140-6736(85)91146-8","journal-title":"Lancet"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(94)92725-1","article-title":"Parvovirus B19 and erosive polyarthritis","volume":"343","author":"Tyndall A","year":"1994","unstructured":"Tyndall A, Jelk W, Hirsch HH. Parvovirus B19 and erosive polyarthritis. Lancet. 1994, 343:480-1. 10.1016\/s0140-6736(94)92725-1","journal-title":"Lancet"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/157.4.663","article-title":"Risk of adverse outcomes of pregnancy after human parvovirus B19 infection","volume":"157","author":"Kinney JS","year":"1988","unstructured":"Kinney JS, Anderson LJ, Farrar J, et al.. Risk of adverse outcomes of pregnancy after human parvovirus B19 infection. J Infect Dis. 1988, 157:663-7. 10.1093\/infdis\/157.4.663","journal-title":"J Infect Dis"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/s1028-4559(08)60014-5","article-title":"Prenatal diagnosis and perinatal management of maternal\u2014fetal congenital parvovirus B19 infection","volume":"46","author":"Hsu ST","year":"2007","unstructured":"Hsu ST, Chen YT, Huang YF, Yeh TT, Chen WC, Ho ES, Chou MM. Prenatal diagnosis and perinatal management of maternal\u2014fetal congenital parvovirus B19 infection. Taiwan J Obstet Gynecol. 2007, 46:417-22. 10.1016\/s1028-4559(08)60014-5","journal-title":"Taiwan J Obstet Gynecol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1007\/s00430-003-0190-1","article-title":"Molecular pathology of inflammatory cardiomyopathy","volume":"193","author":"Klingel K","year":"2004","unstructured":"Klingel K, Sauter M, Bock CT, Szalay G, Schnorr JJ, Kandolf R. Molecular pathology of inflammatory cardiomyopathy. Med Microbiol Immunol. 2004, 193:101-7. 10.1007\/s00430-003-0190-1","journal-title":"Med Microbiol Immunol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000072766.67150.51","article-title":"Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction","volume":"107","author":"K\u00fchl U","year":"2003","unstructured":"K\u00fchl U, Pauschinger M, Schwimmbeck PL, et al.. Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation. 2003, 107:2793-8. 10.1161\/01.CIR.0000072766.67150.51","journal-title":"Circulation"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/s0272-6386(00)70055-2","article-title":"Parvovirus B19 DNA in kidney tissue of patients with focal segmental glomerulosclerosis","volume":"35","author":"Tanawattanacharoen S","year":"2000","unstructured":"Tanawattanacharoen S, Falk RJ, Jennette JC, Kopp JB. Parvovirus B19 DNA in kidney tissue of patients with focal segmental glomerulosclerosis. Am J Kidney Dis. 2000, 35:1166-74. 10.1016\/s0272-6386(00)70055-2","journal-title":"Am J Kidney Dis"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1999.02943.x","article-title":"Parvovirus B19 infection associated with acute hepatitis and a purpuric exanthem","volume":"141","author":"Drago F","year":"1999","unstructured":"Drago F, Semino M, Rampini P, Rebora A. Parvovirus B19 infection associated with acute hepatitis and a purpuric exanthem. Br J Dermatol. 1999, 141:160-1. 10.1046\/j.1365-2133.1999.02943.x","journal-title":"Br J Dermatol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1007\/BF02009384","article-title":"Persistent human parvovirus B19 infection following an acute infection with meningitis in an immunocompetent patient","volume":"12","author":"Cassinotti P","year":"1993","unstructured":"Cassinotti P, Schultze D, Schlageter P, Chevili S, Siegl G. Persistent human parvovirus B19 infection following an acute infection with meningitis in an immunocompetent patient. Eur J Clin Microbiol Infect Dis. 1993, 12:701-4. 10.1007\/BF02009384","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1172\/JCI111195","article-title":"Characterization of a virus that causes transient aplastic crisis","volume":"73","author":"Young NS","year":"1984","unstructured":"Young NS, Mortimer PP, Moore JG, Humphries RK. Characterization of a virus that causes transient aplastic crisis. J Clin Invest. 1984, 73:224-30. 10.1172\/JCI111195","journal-title":"J Clin Invest"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu828","article-title":"Costs of intravenous immunoglobulin therapy in patients with unconfirmed parvovirus b19 pure red cell aplasia","volume":"60","author":"Mouthon L","year":"2015","unstructured":"Mouthon L, Michel M, Gandr\u00e9 C, Montagnier-Petrissans C, Chevreul K. Costs of intravenous immunoglobulin therapy in patients with unconfirmed parvovirus b19 pure red cell aplasia. Clin Infect Dis. 2015, 60:488. 10.1093\/cid\/ciu828","journal-title":"Clin Infect Dis"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1159\/000357650","article-title":"Parvovirus b19 infections and blood counts in blood donors","volume":"41","author":"Juhl D","year":"2014","unstructured":"Juhl D, Steppat D, G\u00f6rg S, Hennig H. Parvovirus b19 infections and blood counts in blood donors. Transfus Med Hemother. 2014, 41:52-9. 10.1159\/000357650","journal-title":"Transfus Med Hemother"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1089\/vim.2020.0022","article-title":"Parvovirus capsid-antibody complex structures reveal conservation of antigenic epitopes across the family","volume":"34","author":"Emmanuel SN","year":"2021","unstructured":"Emmanuel SN, Mietzsch M, Tseng YS, Smith JK, Agbandje-McKenna M. Parvovirus capsid-antibody complex structures reveal conservation of antigenic epitopes across the family. Viral Immunol. 2021, 34:3-17. 10.1089\/vim.2020.0022","journal-title":"Viral Immunol"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2007.01443.x","article-title":"Blood donor screening for parvovirus B19 in Germany and Austria","volume":"47","author":"Schmidt M","year":"2007","unstructured":"Schmidt M, Themann A, Drexler C, et al.. Blood donor screening for parvovirus B19 in Germany and Austria. Transfusion. 2007, 47:1775-82. 10.1111\/j.1537-2995.2007.01443.x","journal-title":"Transfusion"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiac456","article-title":"Prevalence of parvovirus B19 viremia among German blood donations and the relationship to ABO and Rhesus blood group antigens","volume":"227","author":"Healy K","year":"2023","unstructured":"Healy K, Aulin LB, Freij U, et al.. Prevalence of parvovirus B19 viremia among German blood donations and the relationship to ABO and Rhesus blood group antigens. J Infect Dis. 2023, 227:1214-8. 10.1093\/infdis\/jiac456","journal-title":"J Infect Dis"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.21037\/aob.2019.01.01","article-title":"Human parvovirus B19 research concerning the safety of blood and plasma derivatives in China","volume":"4","author":"Jia J","year":"2019","unstructured":"Jia J, Zhang M, Ma Y, Zhang J. Human parvovirus B19 research concerning the safety of blood and plasma derivatives in China. Ann Blood. 2019, 4:2. 10.21037\/aob.2019.01.01","journal-title":"Ann Blood"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1016\/S1701-2163(15)30390-X","article-title":"Parvovirus B19 infection in pregnancy","volume":"36","author":"Crane J","year":"2014","unstructured":"Crane J, Mundle W, Boucoiran I, et al.. Parvovirus B19 infection in pregnancy. J Obstet Gynaecol Can. 2014, 36:1107-16. 10.1016\/S1701-2163(15)30390-X","journal-title":"J Obstet Gynaecol Can"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.3390\/v15030782","article-title":"The role of viral infections in the onset of autoimmune diseases","volume":"15","author":"Sundaresan B","year":"2023","unstructured":"Sundaresan B, Shirafkan F, Ripperger K, Rattay K. The role of viral infections in the onset of autoimmune diseases. Viruses. 2023, 15:782. 10.3390\/v15030782","journal-title":"Viruses"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.6.1958-1962.2002","article-title":"High-sensitivity PCR detection of parvovirus B19 in plasma","volume":"40","author":"Daly P","year":"2002","unstructured":"Daly P, Corcoran A, Mahon BP, Doyle S. High-sensitivity PCR detection of parvovirus B19 in plasma. J Clin Microbiol. 2002, 40:1958-62. 10.1128\/JCM.40.6.1958-1962.2002","journal-title":"J Clin Microbiol"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2010.02591.x","article-title":"Parvovirus B19 infection transmitted by transfusion of red blood cells confirmed by molecular analysis of linked donor and recipient samples","volume":"50","author":"Yu MY","year":"2010","unstructured":"Yu MY, Alter HJ, Virata-Theimer ML, et al.. Parvovirus B19 infection transmitted by transfusion of red blood cells confirmed by molecular analysis of linked donor and recipient samples. Transfusion. 2010, 50:1712-21. 10.1111\/j.1537-2995.2010.02591.x","journal-title":"Transfusion"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1017\/s0950268804002389","article-title":"Seroprevalence of IgG against conformational and linear capsid antigens of parvovirus B19 in Italian blood donors","volume":"132","author":"Manaresi E","year":"2004","unstructured":"Manaresi E, Gallinella G, Morselli Labate AM, et al.. Seroprevalence of IgG against conformational and linear capsid antigens of parvovirus B19 in Italian blood donors. Epidemiol Infect. 2004, 132:857-62. 10.1017\/s0950268804002389","journal-title":"Epidemiol Infect"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2020.e03869","article-title":"Human parvovirus B19 frequency among blood donors after an epidemic outbreak: relevance of the epidemiological scenario for transfusion medicine","volume":"6","author":"Adamo MP","year":"2020","unstructured":"Adamo MP, Blanco S, Viale F, et al.. Human parvovirus B19 frequency among blood donors after an epidemic outbreak: relevance of the epidemiological scenario for transfusion medicine. Heliyon. 2020, 6:e03869. 10.1016\/j.heliyon.2020.e03869","journal-title":"Heliyon"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1159\/000496749","article-title":"History and future of nucleic acid amplification technology blood donor testing","volume":"46","author":"Roth WK","year":"2019","unstructured":"Roth WK. History and future of nucleic acid amplification technology blood donor testing. Transfus Med Hemother. 2019, 46:67-75. 10.1159\/000496749","journal-title":"Transfus Med Hemother"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.4103\/0973-6247.126679","article-title":"Nucleic acid testing-benefits and constraints","volume":"8","author":"Hans R","year":"2014","unstructured":"Hans R, Marwaha N. Nucleic acid testing-benefits and constraints. Asian J Transfus Sci. 2014, 8:2-3. 10.4103\/0973-6247.126679","journal-title":"Asian J Transfus Sci"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00040-16","article-title":"Human parvoviruses","volume":"30","author":"Qiu J","year":"2017","unstructured":"Qiu J, S\u00f6derlund-Venermo M, Young NS. Human parvoviruses. Clin Microbiol Rev. 2017, 30:43-113. 10.1128\/CMR.00040-16","journal-title":"Clin Microbiol Rev"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1002\/sim.7066","article-title":"Residual risk and waste in donated blood with pooled nucleic acid testing","volume":"35","author":"Aprahamian H","year":"2016","unstructured":"Aprahamian H, Bish DR, Bish EK. Residual risk and waste in donated blood with pooled nucleic acid testing. Stat Med. 2016, 35:5283-301. 10.1002\/sim.7066","journal-title":"Stat Med"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2012.03949.x","article-title":"Impact of chemiluminescent enzyme immunoassay screening for human parvovirus B19 antigen in Japanese blood donors","volume":"53","author":"Sakata H","year":"2013","unstructured":"Sakata H, Matsubayashi K, Ihara H, et al.. Impact of chemiluminescent enzyme immunoassay screening for human parvovirus B19 antigen in Japanese blood donors. Transfusion. 2013, 53:2556-66. 10.1111\/j.1537-2995.2012.03949.x","journal-title":"Transfusion"},{"key":"ref68","unstructured":"Blood products and parvovirus B19. (2002). Accessed. August 20, 2024: https:\/\/www.healthcouncil.nl\/binaries\/healthcouncil\/documenten\/advisory-reports\/2002\/05\/30\/bloodproducts-and-parvovir...."},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.21947","article-title":"Identification and characterization of acute infection with parvovirus B19 genotype 2 in immunocompromised patients in Poland","volume":"83","author":"Grabarczyk P","year":"2011","unstructured":"Grabarczyk P, Kali\u0144ska A, Kara M, et al.. Identification and characterization of acute infection with parvovirus B19 genotype 2 in immunocompromised patients in Poland. J Med Virol. 2011, 83:142-9. 10.1002\/jmv.21947","journal-title":"J Med Virol"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1995.tb02595.x","article-title":"Human parvovirus B19 infection in blood donors","volume":"69","author":"Tsujimura M","year":"1995","unstructured":"Tsujimura M, Matsushita K, Shiraki H, Sato H, Okochi K, Maeda Y. Human parvovirus B19 infection in blood donors. Vox Sang. 1995, 69:206-12. 10.1111\/j.1423-0410.1995.tb02595.x","journal-title":"Vox Sang"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1007\/s00705-013-1746-z","article-title":"A population-based epidemiological survey of human parvovirus B19 infection: a project of the Kyushu and Okinawa population study (KOPS)","volume":"158","author":"Ihara T","year":"2013","unstructured":"Ihara T, Furusyo N, Hayashi T, Toyoda K, Murata M, Hayashi J. A population-based epidemiological survey of human parvovirus B19 infection: a project of the Kyushu and Okinawa population study (KOPS). Arch Virol. 2013, 158:2465-72. 10.1007\/s00705-013-1746-z","journal-title":"Arch Virol"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.4103\/0973-6247.67022","article-title":"Standardization of B19 IgG ELISA to study the seroepidemiology of parvovirus B19 in North Indian voluntary blood donors","volume":"4","author":"Kishore J","year":"2010","unstructured":"Kishore J, Srivastava M, Choudhary N. Standardization of B19 IgG ELISA to study the seroepidemiology of parvovirus B19 in North Indian voluntary blood donors. Med J Armed Forces India. 2010, 4:86-90. 10.4103\/0973-6247.67022","journal-title":"Med J Armed Forces India"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1128%2FJVI.78.22.12169-12178.2004","article-title":"Identification and characterization of persistent human erythrovirus infection in blood donor samples","volume":"78","author":"Candotti D","year":"2004","unstructured":"Candotti D, Etiz N, Parsyan A, Allain JP. Identification and characterization of persistent human erythrovirus infection in blood donor samples. J Virol. 2004, 78:12169-78. 10.1128%2FJVI.78.22.12169-12178.2004","journal-title":"J Virol"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.3855\/jidc.1807","article-title":"Molecular and serological assessment of parvovirus B19 infections among sickle cell anemia patients","volume":"5","author":"Obeid OE","year":"2011","unstructured":"Obeid OE. Molecular and serological assessment of parvovirus B19 infections among sickle cell anemia patients. J Infect Dev Ctries. 2011, 5:535-9. 10.3855\/jidc.1807","journal-title":"J Infect Dev Ctries"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2010.01423.x","article-title":"Epidemiology of high-level parvovirus B19 viraemia among Dutch blood donors, 2003-2009","volume":"100","author":"Kooistra K","year":"2011","unstructured":"Kooistra K, Mesman HJ, de Waal M, Koppelman MH, Zaaijer HL. Epidemiology of high-level parvovirus B19 viraemia among Dutch blood donors, 2003-2009. Vox Sang. 2011, 100:261-6. 10.1111\/j.1423-0410.2010.01423.x","journal-title":"Vox Sang"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1159\/000481444","article-title":"Experiences with the NAT testing for parvovirus B19 (B19V) and hepatitis A virus (HAV) in a five years period","volume":"44","author":"Juhl D","year":"2017","unstructured":"Juhl D, Thiessen U, Glessing P, G\u00f6rg S, Hennig H. Experiences with the NAT testing for parvovirus B19 (B19V) and hepatitis A virus (HAV) in a five years period. Transfus Med Hemother. 2017, 44:47. 10.1159\/000481444","journal-title":"Transfus Med Hemother"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.15698","article-title":"Parvovirus B19 DNA and antibodies in Chinese plasma donors, plasma pools and plasma derivatives","volume":"11","author":"Sun P","year":"2023","unstructured":"Sun P, Jiang P, Liu Q, et al.. Parvovirus B19 DNA and antibodies in Chinese plasma donors, plasma pools and plasma derivatives. PeerJ. 2023, 11:e15698. 10.7717\/peerj.15698","journal-title":"PeerJ"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1016\/j.onehlt.2023.100602","article-title":"Plasma metagenomics reveals regional variations of emerging and re-emerging pathogens in Chinese blood donors with an emphasis on human parvovirus B19","volume":"17","author":"Mengyi Z","year":"2023","unstructured":"Mengyi Z, Yuhui L, Zhan G, et al.. Plasma metagenomics reveals regional variations of emerging and re-emerging pathogens in Chinese blood donors with an emphasis on human parvovirus B19. One Health. 2023, 17:100602. 10.1016\/j.onehlt.2023.100602","journal-title":"One Health"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1111\/tme.12893","article-title":"Detection frequencies and viral load distribution of parvovirus B19 DNA in blood and plasma donations in England","volume":"32","author":"Williams S","year":"2022","unstructured":"Williams S, Ratcliff J, Nguyen D, Simmonds P, Harvala H. Detection frequencies and viral load distribution of parvovirus B19 DNA in blood and plasma donations in England. Transfus Med. 2022, 32:402-9. 10.1111\/tme.12893","journal-title":"Transfus Med"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1007\/s12288-020-01356-y","article-title":"Screening for human parvovirus B19 infection in Egyptian family replacement blood donors","volume":"37","author":"Hasanain RH","year":"2021","unstructured":"Hasanain RH, Saleh RM, Attia FM, Gomaa HH. Screening for human parvovirus B19 infection in Egyptian family replacement blood donors. Indian J Hematol Blood Transfus. 2021, 37:309-12. 10.1007\/s12288-020-01356-y","journal-title":"Indian J Hematol Blood Transfus"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.000957","article-title":"Low human parvovirus B19 (B19V) DNA prevalence in blood donors from Central-West Brazil","volume":"68","author":"Slavov SN","year":"2019","unstructured":"Slavov SN, Gon\u00e7alves de Noronha LA, Gonzaga FA, Pimentel BM, Kashima S, Haddad R. Low human parvovirus B19 (B19V) DNA prevalence in blood donors from Central-West Brazil. J Med Microbiol. 2019, 68:622-6. 10.1099\/jmm.0.000957","journal-title":"J Med Microbiol"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25450","article-title":"Parvovirus B19 in South African blood donors","volume":"91","author":"Francois KL","year":"2019","unstructured":"Francois KL, Parboosing R, Moodley P. Parvovirus B19 in South African blood donors. J Med Virol. 2019, 91:1217-23. 10.1002\/jmv.25450","journal-title":"J Med Virol"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2018.07.017","article-title":"Seroprevalence of human parvovirus B19 amongst North Indian blood donors - do current donor testing guidelines need a relook?","volume":"57","author":"Raturi G","year":"2018","unstructured":"Raturi G, Kaur P, Kaur G. Seroprevalence of human parvovirus B19 amongst North Indian blood donors - do current donor testing guidelines need a relook?. Transfus Apher Sci. 2018, 57:646-50. 10.1016\/j.transci.2018.07.017","journal-title":"Transfus Apher Sci"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.3906\/sag-1802-150","article-title":"Parvovirus B19 seroprevalence in Turkish blood donors","volume":"48","author":"G\u00f6ral \u015e","year":"2018","unstructured":"G\u00f6ral \u015e, Yenicesu \u0130, Bozday\u0131 G, Duyan \u00c7amurdan A, Altay Ko\u00e7ak A. Parvovirus B19 seroprevalence in Turkish blood donors. Turk J Med Sci. 2018, 48:956-60. 10.3906\/sag-1802-150","journal-title":"Turk J Med Sci"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-018-3525-7","article-title":"Seroprevalence of antibodies to primate erythroparvovirus 1 (B19V) in Australia","volume":"18","author":"Faddy HM","year":"2018","unstructured":"Faddy HM, Gorman EC, Hoad VC, Frentiu FD, Tozer S, Flower RL. Seroprevalence of antibodies to primate erythroparvovirus 1 (B19V) in Australia. BMC Infect Dis. 2018, 18:631. 10.1186\/s12879-018-3525-7","journal-title":"BMC Infect Dis"},{"key":"ref86","article-title":"Molecular detection of human parvovirus B19 among blood donors in Southern Darfur State, Sudan","volume":"2","author":"Osman EM","year":"2017","unstructured":"Osman EM, Yassin ME, Mohammed AB, Bush NM. Molecular detection of human parvovirus B19 among blood donors in Southern Darfur State, Sudan. Afr J Health Sci. 2017, 2:1-6.","journal-title":"Afr J Health Sci"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1007\/s12288-015-0607-1","article-title":"Prevalence and viral load of human parvovirus B19 (B19V) among blood donors in South-East Brazil","volume":"32","author":"Slavov SN","year":"2016","unstructured":"Slavov SN, Otaguiri KK, Covas DT, Kashima S. Prevalence and viral load of human parvovirus B19 (B19V) among blood donors in South-East Brazil. Indian J Hematol Blood Transfus. 2016, 32:323-5. 10.1007\/s12288-015-0607-1","journal-title":"Indian J Hematol Blood Transfus"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.7534\/j.issn.1009-2137.2016.05.052","article-title":"[Prevalence of parvovirus B19 infection in Chinese Xiamen area blood donors]","volume":"24","author":"Ou SH","year":"2016","unstructured":"Ou SH, Xie JZ, Zhang YL, Ni HY, Song XY. [Prevalence of parvovirus B19 infection in Chinese Xiamen area blood donors]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016, 24:1572-6. 10.7534\/j.issn.1009-2137.2016.05.052","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1111\/tme.12259","article-title":"The prevalence of hepatitis A virus and parvovirus B19 in source-plasma donors and whole blood donors in China","volume":"25","author":"Han T","year":"2015","unstructured":"Han T, Li C, Zhang Y, et al.. The prevalence of hepatitis A virus and parvovirus B19 in source-plasma donors and whole blood donors in China. Transfus Med. 2015, 25:406-10. 10.1111\/tme.12259","journal-title":"Transfus Med"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1016\/j.mjafi.2012.11.009","article-title":"Seroprevalence of human parvovirus B19 in healthy blood donors","volume":"69","author":"Kumar S","year":"2013","unstructured":"Kumar S, Gupta RM, Sen S, Sarkar RS, Philip J, Kotwal A, Sumathi SH. Seroprevalence of human parvovirus B19 in healthy blood donors. Med J Armed Forces India. 2013, 69:268-72. 10.1016\/j.mjafi.2012.11.009","journal-title":"Med J Armed Forces India"},{"key":"ref91","article-title":"[Parvovirus B19 DNA testing in Polish blood donors, 2004-2010]","volume":"66","author":"Grabarczyk P","year":"2012","unstructured":"Grabarczyk P, Korzeniowska J, Liszewski G, et al.. [Parvovirus B19 DNA testing in Polish blood donors, 2004-2010]. Przegl Epidemiol. 2012, 66:7-12.","journal-title":"Przegl Epidemiol"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.21859\/isv.5.2.9","article-title":"Detection of human parvovirus B19 markers in blood samples of donors","volume":"5","author":"Mahmoodian-Shooshtari M","year":"2011","unstructured":"Mahmoodian-Shooshtari M, Sharifi Z. Detection of human parvovirus B19 markers in blood samples of donors. Iran J Virol. 2011, 5:9-12. 10.21859\/isv.5.2.9","journal-title":"Iran J Virol"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2011.03067.x","article-title":"The prevalence of human parvovirus B19 DNA and antibodies in blood donors from four Chinese blood centers","volume":"51","author":"Ke L","year":"2011","unstructured":"Ke L, He M, Li C, et al.. The prevalence of human parvovirus B19 DNA and antibodies in blood donors from four Chinese blood centers. Transfusion. 2011, 51:1909-18. 10.1111\/j.1537-2995.2011.03067.x","journal-title":"Transfusion"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.3343\/kjlm.2010.30.1.58","article-title":"Investigation of the prevalence of human parvovirus B19 DNA in Korean plasmapheresis donors","volume":"30","author":"Oh DJ","year":"2010","unstructured":"Oh DJ, Lee YL, Kang JW, Kwon SY, Cho NS. Investigation of the prevalence of human parvovirus B19 DNA in Korean plasmapheresis donors. Korean J Lab Med. 2010, 30:58-64. 10.3343\/kjlm.2010.30.1.58","journal-title":"Korean J Lab Med"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1177\/0961203310375438","article-title":"Parvovirus B19 and C-reactive protein in blood bank donors: implications for hygiene hypothesis research","volume":"19","author":"O'Bryan TA","year":"2010","unstructured":"O'Bryan TA, Wright WF. Parvovirus B19 and C-reactive protein in blood bank donors: implications for hygiene hypothesis research. Lupus. 2010, 19:1557-60. 10.1177\/0961203310375438","journal-title":"Lupus"},{"key":"ref96","doi-asserted-by":"crossref","DOI":"10.4103\/2230-8229.96529","article-title":"Seroprevalence of erythrovirus B19 IgG among Saudi blood donors in Makkah, Saudi Arabia","volume":"16","author":"Johargy AK","year":"2009","unstructured":"Johargy AK. Seroprevalence of erythrovirus B19 IgG among Saudi blood donors in Makkah, Saudi Arabia. J Fam Community Med. 2009, 16:111-4.","journal-title":"J Fam Community Med"},{"key":"ref97","article-title":"Prevalence of parvovirus B19 in blood donors tested by ELISA and PCR","volume":"5","author":"Mahmudi F","year":"2008","unstructured":"Mahmudi F, Mahmoodian Shooshtari M, Sharifi Z, Hosseinni M. Prevalence of parvovirus B19 in blood donors tested by ELISA and PCR. Sci J Iran Blood Transfus Organ. 2008, 5:47-52.","journal-title":"Sci J Iran Blood Transfus Organ"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2007.01341.x","article-title":"Prevalence and quantitation of parvovirus B19 DNA levels in blood donors with a sensitive polymerase chain reaction screening assay","volume":"47","author":"Kleinman SH","year":"2007","unstructured":"Kleinman SH, Glynn SA, Lee TH, et al.. Prevalence and quantitation of parvovirus B19 DNA levels in blood donors with a sensitive polymerase chain reaction screening assay. Transfusion. 2007, 47:1756-64. 10.1111\/j.1537-2995.2007.01341.x","journal-title":"Transfusion"},{"key":"ref99","article-title":"[Prevalence of anti-human parvovirus B19 IgG antibody among blood donors in Jilin province]","volume":"20","author":"Wei Q","year":"2006","unstructured":"Wei Q, Li Y, Wang JW, Wang H, Qu JG, Hung T. [Prevalence of anti-human parvovirus B19 IgG antibody among blood donors in Jilin province]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2006, 20:60-2.","journal-title":"Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2005.06.002","article-title":"Prevalence of parvovirus B19 and hepatitis A virus in Portuguese blood donors","volume":"33","author":"Henriques I","year":"2005","unstructured":"Henriques I, Monteiro F, Meireles E, Cruz A, Tavares G, Ferreira M, Ara\u00fajo F. Prevalence of parvovirus B19 and hepatitis A virus in Portuguese blood donors. Transfus Apher Sci. 2005, 33:305-9. 10.1016\/j.transci.2005.06.002","journal-title":"Transfus Apher Sci"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1046\/j.1423-0410.2003.00299.x","article-title":"Prevalence of human erythrovirus B19 DNA in healthy Belgian blood donors and correlation with specific antibodies against structural and non-structural viral proteins","volume":"84","author":"Thomas I","year":"2003","unstructured":"Thomas I, Di Giambattista M, G\u00e9rard C, et al.. Prevalence of human erythrovirus B19 DNA in healthy Belgian blood donors and correlation with specific antibodies against structural and non-structural viral proteins. Vox Sang. 2003, 84:300-7. 10.1046\/j.1423-0410.2003.00299.x","journal-title":"Vox Sang"},{"key":"ref102","article-title":"[Seroprevalence versus parvovirus B19 in blood donors]","volume":"16","author":"Mu\u00f1oz S","year":"1998","unstructured":"Mu\u00f1oz S, Alonso MA, Fern\u00e1ndez MJ, Mu\u00f1oz JL, Garc\u00eda-Rodr\u00edguez JA. [Seroprevalence versus parvovirus B19 in blood donors]. Enferm Infecc Microbiol Clin. 1998, 16:161-2.","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.1016\/s0955-3886(97)00049-0","article-title":"Higher prevalence of parvovirus B19 in Belgian as compared to Tunisian blood donors: differential implications for prevention of transfusional transmission","volume":"18","author":"Leta\u00efef M","year":"1997","unstructured":"Leta\u00efef M, Vanham G, Boukef K, Yacoub S, Muylle L, Mertens G. Higher prevalence of parvovirus B19 in Belgian as compared to Tunisian blood donors: differential implications for prevention of transfusional transmission. Transfus Sci. 1997, 18:523-30. 10.1016\/s0955-3886(97)00049-0","journal-title":"Transfus Sci"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb05427.x","article-title":"Incidence of human parvovirus B19 DNA detection in blood donors","volume":"91","author":"Yoto Y","year":"1995","unstructured":"Yoto Y, Kudoh T, Haseyama K, et al.. Incidence of human parvovirus B19 DNA detection in blood donors. Br J Haematol. 1995, 91:1017-8. 10.1111\/j.1365-2141.1995.tb05427.x","journal-title":"Br J Haematol"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1995.35996029163.x","article-title":"Transfusion-transmitted human parvovirus B19 infection in a thalassemic patient","volume":"35","author":"Zanella A","year":"1995","unstructured":"Zanella A, Rossi F, Cesana C, et al.. Transfusion-transmitted human parvovirus B19 infection in a thalassemic patient. Transfusion. 1995, 35:769-72. 10.1046\/j.1537-2995.1995.35996029163.x","journal-title":"Transfusion"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2010.03047.x","article-title":"Symptomatic parvovirus B19 infection caused by blood component transfusion","volume":"51","author":"Satake M","year":"2011","unstructured":"Satake M, Hoshi Y, Taira R, Momose SY, Hino S, Tadokoro K. Symptomatic parvovirus B19 infection caused by blood component transfusion. Transfusion. 2011, 51:1887-95. 10.1111\/j.1537-2995.2010.03047.x","journal-title":"Transfusion"},{"key":"ref107","article-title":"Annual Shot Report 2016","author":"Serious Hazards of Transfusion (SHOT) Steering Group","year":"2017","unstructured":"Serious Hazards of Transfusion (SHOT) Steering Group. Annual Shot Report 2016. Bolton-Maggs P (ed): Serious Hazards of Transfusion (SHOT), Manchester, UK; 2017."},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2010.01390.x","article-title":"Limits of sequencing and phylogenetic analysis to assess B19V transmission by single-donor blood component","volume":"100","author":"Servant-Delmas A","year":"2011","unstructured":"Servant-Delmas A, Laperche S, Mercier M, et al.. Limits of sequencing and phylogenetic analysis to assess B19V transmission by single-donor blood component. Vox Sang. 2011, 100:254-5. 10.1111\/j.1423-0410.2010.01390.x","journal-title":"Vox Sang"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.1046\/j.0041-1132.2004.00610.x","article-title":"Quantitative real-time detection of parvovirus B19 DNA in plasma","volume":"44","author":"Koppelman MH","year":"2004","unstructured":"Koppelman MH, Cuypers HT, Emrich T, Zaaijer HL. Quantitative real-time detection of parvovirus B19 DNA in plasma. Transfusion. 2004, 44:97-103. 10.1046\/j.0041-1132.2004.00610.x","journal-title":"Transfusion"},{"key":"ref110","unstructured":"Guidance for industry. nucleic acid testing (NAT) to reduce the possible risk of parvovirus B19 transmission by plasma-derived products. (2009). Accessed: August 20, 2024: https:\/\/www.fda.gov\/files\/vaccines%2C%20blood%20%26%20biologics\/published\/Guidance-for-Industry---Nucleic-Acid-Testin...."},{"key":"ref111","unstructured":"Guideline for human immunoglobulin. (2023). Accessed. August 20, 2024: https:\/\/www.google.com\/url?sa=t&amp;source=web&amp;rct=j&amp;opi=89978449&amp;url=https:\/\/www.edqm.eu\/documents\/52006\/293206\/OCABR%2B...."},{"key":"ref112","unstructured":"Guideline for human plasma (pooled and treated for virus inactivation) (formerly called solvent detergent (SD) plasma). (2015). Accessed. August 20, 2024: https:\/\/www.edqm.eu\/documents\/52006\/293206\/OCABR+Guideline+06+-+Human+Plasma+(pooled+and+treated+for+virus+inactivati...."},{"key":"ref113","unstructured":"QSEAL NAT testing standard. (2013). Accessed. August 20, 2024: https:\/\/uploads-ssl.webflow.com\/638f893112c6eac0e46ac576\/64517906a60bdb04ed8c3b74_NATTestingV2-3.pdf."},{"key":"ref114","unstructured":"Risks posed by reported increased circulation of human parvovirus B19 in the EU\/EEA. (2024). Accessed. August 20, 2024: https:\/\/ecdc.europa.eu\/en\/publications-data\/risks-posed-reported-increased-circulation-human-parvovirus-b19-eueea."},{"key":"ref115","doi-asserted-by":"publisher","DOI":"10.1111\/trf.15324","article-title":"An assessment of the risk, cost-effectiveness, and perceived benefits of anti-parvovirus B19 tested blood products","volume":"59","author":"van Hoeven LR","year":"2019","unstructured":"van Hoeven LR, Janssen MP, Lieshout-Krikke RW, Molenaar-de Backer MW. An assessment of the risk, cost-effectiveness, and perceived benefits of anti-parvovirus B19 tested blood products. Transfusion. 2019, 59:2352-60. 10.1111\/trf.15324","journal-title":"Transfusion"},{"key":"ref116","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-10-194","article-title":"Parvovirus B19V DNA contamination in Chinese plasma and plasma derivatives","volume":"10","author":"Zhang W","year":"2012","unstructured":"Zhang W, Ke L, Changqing L, Zhang Y, Li W. Parvovirus B19V DNA contamination in Chinese plasma and plasma derivatives. J Transl Med. 2012, 10:194. 10.1186\/1479-5876-10-194","journal-title":"J Transl Med"},{"key":"ref117","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2005.00610.x","article-title":"Exposure of hematologic patients to parvovirus B19 as a contaminant of blood cell preparations and blood products","volume":"45","author":"Plentz A","year":"2005","unstructured":"Plentz A, Hahn J, Kn\u00f6ll A, Holler E, Jilg W, Modrow S. Exposure of hematologic patients to parvovirus B19 as a contaminant of blood cell preparations and blood products. Transfusion. 2005, 45:1811-5. 10.1111\/j.1537-2995.2005.00610.x","journal-title":"Transfusion"},{"key":"ref118","article-title":"Testing and analysis of human parvovirus B19 gene in blood products","volume":"5","author":"Zheng RB","year":"2015","unstructured":"Zheng RB, Yu Y. Testing and analysis of human parvovirus B19 gene in blood products. China Med Pharm. 2015, 5:151-3.","journal-title":"China Med Pharm"},{"key":"ref119","article-title":"Preliminary study on the contamination and genotype of human parvovirus B19 in Chinese blood products","volume":"29","author":"Wu Y","year":"2009","unstructured":"Wu Y, Geng YS, Wang JZ, et al.. Preliminary study on the contamination and genotype of human parvovirus B19 in Chinese blood products. Chin J Microbiol Immunol. 2009, 29:1031-4.","journal-title":"Chin J Microbiol Immunol"},{"key":"ref120","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2012.03907.x","article-title":"Evidence for the transmission of parvovirus B19 in patients with bleeding disorders treated with plasma-derived factor concentrates in the era of nucleic acid test screening","volume":"53","author":"Soucie JM","year":"2013","unstructured":"Soucie JM, De Staercke C, Monahan PE, et al.. Evidence for the transmission of parvovirus B19 in patients with bleeding disorders treated with plasma-derived factor concentrates in the era of nucleic acid test screening. Transfusion. 2013, 53:1217-25. 10.1111\/j.1537-2995.2012.03907.x","journal-title":"Transfusion"},{"key":"ref121","doi-asserted-by":"publisher","DOI":"10.1016\/s1386-6532(00)00149-9","article-title":"Validation and standardisation of nucleic acid amplification technology (NAT) assays for the detection of viral contamination of blood and blood products","volume":"20","author":"Saldanha J","year":"2001","unstructured":"Saldanha J. Validation and standardisation of nucleic acid amplification technology (NAT) assays for the detection of viral contamination of blood and blood products. J Clin Virol. 2001, 20:7-13. 10.1016\/s1386-6532(00)00149-9","journal-title":"J Clin Virol"},{"key":"ref122","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2000.40101203.x","article-title":"Clinical illness due to parvovirus B19 infection after infusion of solvent\/detergent-treated pooled plasma","volume":"40","author":"Koenigbauer UF","year":"2000","unstructured":"Koenigbauer UF, Eastlund T, Day JW. Clinical illness due to parvovirus B19 infection after infusion of solvent\/detergent-treated pooled plasma. Transfusion. 2000, 40:1203-6. 10.1046\/j.1537-2995.2000.40101203.x","journal-title":"Transfusion"},{"key":"ref123","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1994.tb01647.x","article-title":"Nanofiltration, a new specific virus elimination method applied to high-purity factor IX and factor XI concentrates","volume":"67","author":"Burnouf-Radosevich M","year":"1994","unstructured":"Burnouf-Radosevich M, Appourchaux P, Huart JJ, Burnouf T. Nanofiltration, a new specific virus elimination method applied to high-purity factor IX and factor XI concentrates. Vox Sang. 1994, 67:132-8. 10.1111\/j.1423-0410.1994.tb01647.x","journal-title":"Vox Sang"},{"key":"ref124","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.21289","article-title":"Tissue persistence of parvovirus B19 genotypes in asymptomatic persons","volume":"80","author":"Corcioli F","year":"2008","unstructured":"Corcioli F, Zakrzewska K, Rinieri A, et al.. Tissue persistence of parvovirus B19 genotypes in asymptomatic persons. J Med Virol. 2008, 80:2005-11. 10.1002\/jmv.21289","journal-title":"J Med Virol"},{"key":"ref125","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9071(199711)53:3<229::AID-JMV8>3.0.CO;2-A","article-title":"Evidence for persistence of human parvovirus B19 DNA in bone marrow","volume":"53","author":"Cassinotti P","year":"1997","unstructured":"Cassinotti P, Burtonboy G, Fopp M, Siegl G. Evidence for persistence of human parvovirus B19 DNA in bone marrow. J Med Virol. 1997, 53:229-32. 10.1002\/(SICI)1096-9071(199711)53:3&lt;229::AID-JMV8&gt;3.0.CO;2-A","journal-title":"J Med Virol"},{"key":"ref126","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0602259103","article-title":"Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue","volume":"103","author":"Norja P","year":"2006","unstructured":"Norja P, Hokynar K, Aaltonen LM, et al.. Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue. Proc Natl Acad Sci U S A. 2006, 103:7450-3. 10.1073\/pnas.0602259103","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref127","doi-asserted-by":"publisher","DOI":"10.1136\/ard.59.9.672","article-title":"Pathogenesis of human parvovirus B19 in rheumatic disease","volume":"59","author":"Kerr JR","year":"2000","unstructured":"Kerr JR. Pathogenesis of human parvovirus B19 in rheumatic disease. Ann Rheum Dis. 2000, 59:672-83. 10.1136\/ard.59.9.672","journal-title":"Ann Rheum Dis"},{"key":"ref128","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2014.06.017","article-title":"Persistent parvovirus B19 infection in non-erythroid tissues: possible role in the inflammatory and disease process","volume":"190","author":"Adamson-Small LA","year":"2014","unstructured":"Adamson-Small LA, Ignatovich IV, Laemmerhirt MG, Hobbs JA. Persistent parvovirus B19 infection in non-erythroid tissues: possible role in the inflammatory and disease process. Virus Res. 2014, 190:8-16. 10.1016\/j.virusres.2014.06.017","journal-title":"Virus Res"},{"key":"ref129","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)09110-6","article-title":"Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy","volume":"349","author":"S\u00f6derlund M","year":"1997","unstructured":"S\u00f6derlund M, von Essen R, Haapasaari J, Kiistala U, Kiviluoto O, Hedman K. Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy. Lancet. 1997, 349:1063-5. 10.1016\/S0140-6736(96)09110-6","journal-title":"Lancet"},{"key":"ref130","doi-asserted-by":"publisher","DOI":"10.1016\/S0369-8114(02)00307-3","article-title":"Persistence of human parvovirus B19 in human tissues","volume":"50","author":"S\u00f6derlund-Venermo M","year":"2002","unstructured":"S\u00f6derlund-Venermo M, Hokynar K, Nieminen J, Rautakorpi H, Hedman K. Persistence of human parvovirus B19 in human tissues. Pathol Biol (Paris). 2002, 50:307-16. 10.1016\/S0369-8114(02)00307-3","journal-title":"Pathol Biol (Paris)"},{"key":"ref131","doi-asserted-by":"publisher","DOI":"10.2217\/17460794.2.4.377","article-title":"Tissue persistence and prevalence of B19 virus types 1-3","volume":"2","author":"Hokynar K","year":"2007","unstructured":"Hokynar K, Norja P, Hedman K, S\u00f6derlund-Venermo M. Tissue persistence and prevalence of B19 virus types 1-3. Future Virol. 2007, 2:377-88. 10.2217\/17460794.2.4.377","journal-title":"Future Virol"},{"key":"ref132","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2013.07.007","article-title":"Low-level DNAemia of parvovirus B19 (genotypes 1-3) in adult transplant recipients is not associated with anaemia","volume":"58","author":"Plentz A","year":"2013","unstructured":"Plentz A, W\u00fcrdinger M, Kudlich M, Modrow S. Low-level DNAemia of parvovirus B19 (genotypes 1-3) in adult transplant recipients is not associated with anaemia. J Clin Virol. 2013, 58:443-8. 10.1016\/j.jcv.2013.07.007","journal-title":"J Clin Virol"},{"key":"ref133","doi-asserted-by":"publisher","DOI":"10.1016\/s0887-7963(99)80033-9","article-title":"The transfusion-associated transmission of parvovirus B19","volume":"13","author":"Azzi A","year":"1999","unstructured":"Azzi A, Morfini M, Mannucci PM. The transfusion-associated transmission of parvovirus B19. Transfus Med Rev. 1999, 13:194-204. 10.1016\/s0887-7963(99)80033-9","journal-title":"Transfus Med Rev"},{"key":"ref134","doi-asserted-by":"publisher","DOI":"10.3390\/v15030595","article-title":"Novel nucleic acid detection for human parvovirus B19 based on Pyrococcus furiosus Argonaute protein","volume":"15","author":"Chen W","year":"2023","unstructured":"Chen W, Qiu L, Luo T, et al.. Novel nucleic acid detection for human parvovirus B19 based on Pyrococcus furiosus Argonaute protein. Viruses. 2023, 15:595. 10.3390\/v15030595","journal-title":"Viruses"},{"key":"ref135","doi-asserted-by":"publisher","DOI":"10.1086\/513280","article-title":"Comparison of tissue distribution, persistence, and molecular epidemiology of parvovirus B19 and novel human parvoviruses PARV4 and human bocavirus","volume":"195","author":"Manning A","year":"2007","unstructured":"Manning A, Willey SJ, Bell JE, Simmonds P. Comparison of tissue distribution, persistence, and molecular epidemiology of parvovirus B19 and novel human parvoviruses PARV4 and human bocavirus. J Infect Dis. 2007, 195:1345-52. 10.1086\/513280","journal-title":"J Infect Dis"},{"key":"ref136","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.13.8230-8236.2005","article-title":"New DNA viruses identified in patients with acute viral infection syndrome","volume":"79","author":"Jones MS","year":"2005","unstructured":"Jones MS, Kapoor A, Lukashov VV, Simmonds P, Hecht F, Delwart E. New DNA viruses identified in patients with acute viral infection syndrome. J Virol. 2005, 79:8230-6. 10.1128\/JVI.79.13.8230-8236.2005","journal-title":"J Virol"},{"key":"ref137","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0504666102","article-title":"Cloning of a human parvovirus by molecular screening of respiratory tract samples","volume":"102","author":"Allander T","year":"2005","unstructured":"Allander T, Tammi MT, Eriksson M, Bjerkner A, Tiveljung-Lindell A, Andersson B. Cloning of a human parvovirus by molecular screening of respiratory tract samples. Proc Natl Acad Sci U S A. 2005, 102:12891-6. 10.1073\/pnas.0504666102","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref138","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens12081007","article-title":"Therapeutic potential of engineered virus-like particles of parvovirus B19","volume":"12","author":"S\u00e1nchez-Moguel I","year":"2023","unstructured":"S\u00e1nchez-Moguel I, Montiel C, Bustos-Jaimes I. Therapeutic potential of engineered virus-like particles of parvovirus B19. Pathogens. 2023, 12:1007. 10.3390\/pathogens12081007","journal-title":"Pathogens"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/278449-ensuring-transfusion-safety-screening-blood-donors-for-human-parvovirus-b19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:35:18Z","timestamp":1724286918000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/278449-ensuring-transfusion-safety-screening-blood-donors-for-human-parvovirus-b19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,21]]},"references-count":138,"URL":"https:\/\/doi.org\/10.7759\/cureus.67359","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,21]]}}}